Follow
International Journal of Current Microbiology and Applied Sciences (IJCMAS)
IJCMAS is now DOI (CrossRef) registered Research Journal. The DOIs are assigned to all published IJCMAS Articles.
Index Copernicus ICI Journals Master List 2018 - IJCMAS--ICV 2018: 95.39 For more details click here
National Academy of Agricultural Sciences (NAAS) : NAAS Score: *5.38 (2020) [Effective from January 1, 2020]For more details click here

Login as a Reviewer

Indexed in



National Academy of Agricultural Sciences (NAAS)
NAAS Score: *5.38 (2019)
[Effective from January 1, 2019]
For more details click here

ICV 2018: 95.39
Index Copernicus ICI Journals Master List 2017 - IJCMAS--ICV 2018: 95.39
For more details click here

See Guidelines to Authors
Current Issues

Original Research Articles

PRINT ISSN : 2319-7692
Online ISSN : 2319-7706
Issues : 12 per year
Publisher : Excellent Publishers
Email : editorijcmas@gmail.com / submit@ijcmas.com
Editor-in-chief: Dr.M.Prakash
Index Copernicus ICV 2018: 95.39
NAAS RATING 2020: 5.38

Int.J.Curr.Microbiol.App.Sci.2018.7(4): 1448-1463
DOI: https://doi.org/10.20546/ijcmas.2018.704.164


Multi Drug Resistant Acinetobacter Ventilator Associated Pneumonia in a Tertiary Care Hospital
P. Nanthini Devi1 and S. Gomathi2
1Department of Microbiology, Sree Balaji Medical College and Hospital, Chennai, Tamil Nadu, India
2Department of Microbiology, SRM Medical College Hospital and Research Centre, Chennai, Tamil Nadu, India
*Corresponding author
Abstract:

Ventilator associated pneumonia (VAP) is a common hospital acquired infection. Its prevalence ranges from 9-24%. It leads to increased mortality and increased health care costs. VAP due to Acinetobacter baumannii is notorious for its multidrug resistance potential. The study reveals the characteristics of Acinetobacter baumanii in a tertiary care hospital. This is a prospective study of 100 patients. The endotracheal aspirates were collected, processed and isolate identified. Antimicrbial susceptibility testing was done, biofilm testing and MIC testing for Meropenem was also done. The incidence of Acinetobacter VAP was 31%. Multisystem disorders and neurological disorders were associated with Acinetobacter VAP. 83.87% isolates were multidrug resistant. 54.84% of isolates were strong biofilm producers. 61.29% of isolates were resistant to Meropenem by MIC testing by microbroth dilution method. Proper infection control measures, judicious use of antibiotics with implementation of ventilator care bundle will retard the development of VAP in ICU.


Keywords: Ventilator associated pneumonia, Acinetobacter baumannii, Multi drug resistance, Biofilm production
Download this article as Download

How to cite this article:

Nanthini Devi, P. and Gomathi, S. 2018. Multi Drug Resistant Acinetobacter Ventilator Associated Pneumonia in a Tertiary Care Hospital.Int.J.Curr.Microbiol.App.Sci. 7(4): 1448-1463. doi: https://doi.org/10.20546/ijcmas.2018.704.164